Sunshine Biopharma Inc. Proceeds from Notes Payable
Sunshine Biopharma Inc. (SBFM) reported Proceeds from Notes Payable of $0 for the 12-month period ending 2022-12-31, per its 10-K filed 2023-04-04.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromNotesPayable · last filed 2023-04-04
- Sunshine Biopharma Inc. proceeds from notes payable for the quarter ending 2021-12-31 was $0.00, a 100.00% decline year-over-year.
- Sunshine Biopharma Inc. proceeds from notes payable for the quarter ending 2021-09-30 was $1.40M, a 168.39% increase year-over-year.
- Sunshine Biopharma Inc. proceeds from notes payable for the quarter ending 2021-06-30 was $768.50K, a 395.78% increase year-over-year.
- Sunshine Biopharma Inc. proceeds from notes payable for the quarter ending 2021-03-31 was $1.15M.
- Sunshine Biopharma Inc. proceeds from notes payable for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
- Sunshine Biopharma Inc. proceeds from notes payable for fiscal 2021 was $3.32M, a 98.21% increase from fiscal 2020.
- Sunshine Biopharma Inc. proceeds from notes payable for fiscal 2020 was $1.67M, a 279.45% increase from fiscal 2019.
- Sunshine Biopharma Inc. proceeds from notes payable for fiscal 2019 was $441.23K, a 27.65% decline from fiscal 2018.
| Period end | Proceeds from Notes Payable 3 month | Proceeds from Notes Payable 6 month | Proceeds from Notes Payable 9 month | Proceeds from Notes Payable 12 month | Proceeds from Notes Payable 31 month | Proceeds from Notes Payable 34 month | Proceeds from Notes Payable 37 month | Proceeds from Notes Payable 40 month | Proceeds from Notes Payable 43 month | Proceeds from Notes Payable 46 month | Proceeds from Notes Payable 49 month | Proceeds from Notes Payable 55 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-12-31 | $0.00 10-K · filed 2023-04-04 | |||||||||||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-04-04 | $1.40M derived: sum of 2 quarters · filed 2023-04-04 | $2.17M derived: sum of 3 quarters · filed 2023-04-04 | $3.32M 10-K · filed 2023-04-04 | ||||||||
| 2021-09-30 | $1.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $2.17M derived: sum of 2 quarters · filed 2021-11-09 | $3.32M 10-Q · filed 2021-11-09 | $4.32M derived: sum of 4 quarters · filed 2022-03-21 | ||||||||
| 2021-06-30 | $768.50K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | $1.92M 10-Q · filed 2021-08-09 | $2.92M derived: sum of 3 quarters · filed 2022-03-21 | $3.44M derived: sum of 4 quarters · filed 2022-03-21 | ||||||||
| 2021-03-31 | $1.15M 10-Q · filed 2021-05-11 | $2.15M derived: sum of 2 quarters · filed 2022-03-21 | $2.67M derived: sum of 3 quarters · filed 2022-03-21 | $2.82M derived: sum of 4 quarters · filed 2022-03-21 | ||||||||
| 2020-12-31 | $997.60K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-21 | $1.52M derived: sum of 2 quarters · filed 2022-03-21 | $1.67M derived: sum of 3 quarters · filed 2022-03-21 | $1.67M 10-K · filed 2022-03-21 | ||||||||
| 2020-09-30 | $521.64K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $676.64K derived: sum of 2 quarters · filed 2021-11-09 | $676.64K 10-Q · filed 2021-11-09 | $741.87K derived: sum of 4 quarters · filed 2021-11-09 | ||||||||
| 2020-06-30 | $155.01K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | $155.01K 10-Q · filed 2021-08-09 | $220.24K derived: sum of 3 quarters · filed 2021-08-09 | $346.74K derived: sum of 4 quarters · filed 2021-08-09 | ||||||||
| 2020-03-31 | $0.00 10-Q · filed 2021-05-11 | $65.23K derived: sum of 2 quarters · filed 2021-05-11 | $191.73K derived: sum of 3 quarters · filed 2021-05-11 | $191.73K derived: sum of 4 quarters · filed 2021-05-11 | ||||||||
| 2019-12-31 | $65.23K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-30 | $191.73K derived: sum of 2 quarters · filed 2021-03-30 | $191.73K derived: sum of 3 quarters · filed 2021-03-30 | $441.23K 10-K · filed 2021-03-30 | ||||||||
| 2019-09-30 | $126.50K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2020-11-12 | $126.50K derived: sum of 2 quarters · filed 2020-11-12 | $376.00K 10-Q · filed 2020-11-12 | $553.00K derived: sum of 4 quarters · filed 2020-11-12 | ||||||||
| 2019-06-30 | $0.00 derived: 10-Q/A 6 month − 10-Q 3 month · filed 2020-08-31 | $249.50K 10-Q/A · filed 2020-08-31 | $426.50K derived: sum of 3 quarters · filed 2020-08-31 | $477.50K derived: sum of 4 quarters · filed 2020-08-31 | ||||||||
| 2019-03-31 | $249.50K 10-Q · filed 2020-05-18 | $426.50K derived: sum of 2 quarters · filed 2020-05-18 | $477.50K derived: sum of 3 quarters · filed 2020-05-18 | $502.50K derived: sum of 4 quarters · filed 2020-05-18 | ||||||||
| 2018-12-31 | $177.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-05-01 | $228.00K derived: sum of 2 quarters · filed 2020-05-01 | $253.00K derived: sum of 3 quarters · filed 2020-05-01 | $609.88K 10-K · filed 2020-05-01 | ||||||||
| 2018-09-30 | $51.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-13 | $76.00K derived: sum of 2 quarters · filed 2019-11-13 | $432.88K 10-Q · filed 2019-11-13 | $689.01K derived: sum of 4 quarters · filed 2019-11-13 | ||||||||
| 2018-06-30 | $25.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-15 | $381.88K 10-Q · filed 2019-08-15 | $638.01K derived: sum of 3 quarters · filed 2019-08-15 | $854.01K derived: sum of 4 quarters · filed 2019-08-15 | ||||||||
| 2018-03-31 | $356.88K 10-Q · filed 2019-05-20 | $613.01K derived: sum of 2 quarters · filed 2019-05-20 | $829.01K derived: sum of 3 quarters · filed 2019-05-20 | $967.19K derived: sum of 4 quarters · filed 2019-05-20 | ||||||||
| 2017-12-31 | $256.12K derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-12 | $472.12K derived: sum of 2 quarters · filed 2019-04-12 | $610.31K derived: sum of 3 quarters · filed 2019-04-12 | $660.57K 10-K · filed 2019-04-12 | ||||||||
| 2017-09-30 | $216.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-16 | $354.19K derived: sum of 2 quarters · filed 2018-11-16 | $404.44K 10-Q · filed 2018-11-16 | $404.44K derived: sum of 4 quarters · filed 2018-11-16 | ||||||||
| 2017-06-30 | $138.19K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-17 | $188.44K 10-Q · filed 2018-08-17 | $188.44K derived: sum of 3 quarters · filed 2018-08-17 | $188.44K derived: sum of 4 quarters · filed 2018-08-17 | ||||||||
| 2017-03-31 | $50.26K 10-Q · filed 2018-05-22 | $50.26K derived: sum of 2 quarters · filed 2018-05-22 | $50.26K derived: sum of 3 quarters · filed 2018-05-22 | $99.41K derived: sum of 4 quarters · filed 2018-05-22 | ||||||||
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-02 | $0.00 derived: sum of 2 quarters · filed 2018-04-02 | $49.15K derived: sum of 3 quarters · filed 2018-04-02 | $131.15K 10-K · filed 2018-04-02 | ||||||||
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-15 | $49.15K derived: sum of 2 quarters · filed 2017-11-15 | $131.15K 10-Q · filed 2017-11-15 | $131.15K derived: sum of 4 quarters · filed 2017-11-15 | ||||||||
| 2016-06-30 | $49.15K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-11 | $131.15K 10-Q · filed 2017-08-11 | $131.15K derived: sum of 3 quarters · filed 2017-08-11 | $211.15K derived: sum of 4 quarters · filed 2017-08-11 | ||||||||
| 2016-03-31 | $82.00K 10-Q · filed 2017-05-12 | $82.00K derived: sum of 2 quarters · filed 2017-05-12 | $162.00K derived: sum of 3 quarters · filed 2017-05-12 | $314.84K derived: sum of 4 quarters · filed 2017-05-12 | ||||||||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-04-17 | $80.00K derived: sum of 2 quarters · filed 2017-04-17 | $232.84K derived: sum of 3 quarters · filed 2017-04-17 | $232.84K 10-K · filed 2017-04-17 | ||||||||
| 2015-09-30 | $80.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | $232.84K derived: sum of 2 quarters · filed 2016-11-14 | $232.84K 10-Q · filed 2016-11-14 | $354.34K derived: sum of 4 quarters · filed 2016-11-14 | ||||||||
| 2015-06-30 | $152.84K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-16 | $152.84K 10-Q · filed 2016-08-16 | $274.34K derived: sum of 3 quarters · filed 2016-08-16 | $387.84K derived: sum of 4 quarters · filed 2016-08-16 | ||||||||
| 2015-03-31 | $0.00 10-Q · filed 2016-05-09 | $121.50K derived: sum of 2 quarters · filed 2016-05-09 | $235.00K derived: sum of 3 quarters · filed 2016-05-09 | $335.00K derived: sum of 4 quarters · filed 2016-05-09 | ||||||||
| 2014-12-31 | $121.50K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-25 | $235.00K derived: sum of 2 quarters · filed 2016-03-25 | $335.00K derived: sum of 3 quarters · filed 2016-03-25 | $395.00K 10-K · filed 2016-03-25 | ||||||||
| 2014-09-30 | $113.50K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-04 | $213.50K derived: sum of 2 quarters · filed 2015-11-04 | $273.50K 10-Q · filed 2015-11-04 | $273.50K derived: sum of 4 quarters · filed 2015-11-04 | ||||||||
| 2014-06-30 | $100.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | $160.00K 10-Q · filed 2015-08-06 | $160.00K derived: sum of 3 quarters · filed 2015-08-06 | $160.00K derived: sum of 4 quarters · filed 2015-08-06 | ||||||||
| 2014-03-31 | $60.00K 10-Q · filed 2015-05-07 | $60.00K derived: sum of 2 quarters · filed 2015-05-07 | $60.00K derived: sum of 3 quarters · filed 2015-05-07 | $60.00K derived: sum of 4 quarters · filed 2015-05-07 | $585.50K 10-Q · filed 2014-05-09 | |||||||
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-11 | $0.00 derived: sum of 2 quarters · filed 2015-03-11 | $0.00 derived: sum of 3 quarters · filed 2015-03-11 | $463.00K 10-K · filed 2015-03-11 | $525.50K 10-K · filed 2014-03-19 | |||||||
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-12 | $0.00 derived: sum of 2 quarters · filed 2014-11-12 | $463.00K 10-Q · filed 2014-11-12 | $513.00K derived: sum of 4 quarters · filed 2014-11-12 | $525.50K 10-Q · filed 2013-11-04 | |||||||
| 2013-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-12 | $463.00K 10-Q · filed 2014-08-12 | $513.00K derived: sum of 3 quarters · filed 2014-08-12 | $513.00K derived: sum of 4 quarters · filed 2014-08-12 | $525.50K 10-Q · filed 2013-08-06 | |||||||
| 2013-03-31 | $463.00K 10-Q · filed 2014-05-09 | $513.00K derived: sum of 2 quarters · filed 2014-05-09 | $513.00K derived: sum of 3 quarters · filed 2014-05-09 | $513.00K derived: sum of 4 quarters · filed 2014-05-09 | $525.50K 10-Q · filed 2013-05-09 | |||||||
| 2012-12-31 | $50.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-19 | $50.00K derived: sum of 2 quarters · filed 2014-03-19 | $50.00K derived: sum of 3 quarters · filed 2014-03-19 | $62.50K 10-K · filed 2014-03-19 | $62.50K 10-K · filed 2013-03-15 | |||||||
| 2012-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-04 | $0.00 derived: sum of 2 quarters · filed 2013-11-04 | $12.50K 10-Q · filed 2013-11-04 | $12.50K 10-Q · filed 2012-11-08 | ||||||||
| 2012-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-06 | $12.50K 10-Q · filed 2013-08-06 | $12.50K 10-Q · filed 2012-08-08 | |||||||||
| 2012-03-31 | $12.50K 10-Q · filed 2013-05-09 | $12.50K 10-Q · filed 2012-05-08 | ||||||||||
| 2011-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-08 | $0.00 derived: sum of 2 quarters · filed 2012-11-08 | $0.00 10-Q · filed 2012-11-08 | |||||||||
| 2011-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-08 | $0.00 10-Q · filed 2012-08-08 | ||||||||||
| 2011-03-31 | $0.00 10-Q · filed 2012-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |